Same company selling same drug under different brand names and at different prices is even more inexplicable.
The department of telecommunications (DoT) has sought clarifications…
Indian pharma giants like Glenmark, Sun, Dr Reddy’s and others are betting on the first-to-files.
Decks have been cleared for the approval of R5,500-crore worth foreign direct investment proposals in brownfield pharmaceutical projects involving transfer…
Drug price regulator asked to consider antiseptic liquid emulsion and not elixir
In its latest submission to the department of industrial policy and promotion (DIPP) last week, US-based Mylan said that the…
US FDA has asked Torrent Pharmaceuticals to recall Olanzapine tablets.
History shows that production cuts are more common in the govt sector than among private firms
Pioglitazone has market sales of over R800 crore, whereas analgin is a mere Rs 40 crore.
The Department of Pharmaceuticals (DoP) is clear that drug companies will not be allowed to sell old stocks of essential…
A consensus seems to have emerged within the government over FDI in brownfield pharma with the Foreign Investment Promotion Board…
In short term, there is also an added threat to some of the leading drug companies
The $22-billion pharma giant Abbott plans to enter new therapeutic areas and launch new molecules to earn more than 50%…
DIPP retreats from its earlier position of opposing M&As in drug industry, proposes rider based on market-share threshold
Shares of Ranbaxy Laboratories rose to R317.60 on Thursday after falling to a 52-week low of R301.75 on June 25,…
The Mylan-Strides deal will be the third-largest acquisition in the pharma sector.
The National Pharmaceutical Pricing Authority (NPPA) will change the ceiling prices of medicines ? notified on Monday ? which brought…
The method of calculating ceiling prices of essential drugs has kicked up a row even as the National Pharmaceutical Pricing…
